Tan et al.’s research elucidated GLY’s multifaceted benefits in T2DM management, encompassing reductions in blood sugar and insulin levels, the amelioration of insulin resistance and glucose tolerance, the modulation of lipid metabolism, and the augmentation of insulin secretion. The gene discussed is INS; the disease is Insulin resistance.